This cross-species translational research project will use specific laboratory-based measures of gating and inhibitory functions to better understand the convergence and divergence of information-processing abnormalities in schizophrenia patients, and elucidate the clinical significance and neurobiological substrates of these abnormalities. The measures are: 1) prepulse inhibition of startle (PPI); 2) P50 (humans) and N40 (animals) event-related potential suppression; 3) startle habituation and 4) oculomotor antisaccade performance. Although groups of schizophrenia patients have deficits on each of these 4 measures, any single patient may exhibit deficits in some but not all of the measures. Similarly, in animals, pharmacological, neuroanatomical, and genetic manipulations have differential effects on these measures. Hence, 300 medicated, 100 non-medicated patients, and 200 normal subjects will be tested on all 4 inhibitory measures. The human research aims are to: 1) confirm and extend findings of inhibitory deficits in schizophrenia patients; 2) identify subgroups of schizophrenia patients based on patterns of deficits in the 4 inhibitory measures; 3) determine how subgroup membership and individual inhibitory deficits relate to clinical domains of demographic, symptom, neurocognitive, and functional status; 4) study patients over time to examine the stability and clinical importance of both subgroups and inhibitory measures. In animals, the project will assess similarities and differences among PPI, N40 suppression, and habituation measures, using parametric, pharmacological, and molecular biological manipulations in mice, rats, and marmosets. Simultaneous measures of PPI, N40 suppression, and/or habituation will be used in rats to assess the effects of psychotomimetic dopaminergic, serotonergic, and glutamatergic drugs. The role of specific receptors in the effects of antipsychotic drugs on inhibitory measures will be assessed in genetically engineered mice. Differential neural substrates of inhibitory measures will be identified using anatomically specific manipulations of the thalamus or ventral hippocampus in rats. Thus, this proposal is designed to """"""""parse"""""""" groups of schizophrenia patients according to convergence and divergence of inhibitory deficits, to examine both """"""""bottom up"""""""" applications (e.g. assessing the relationships of inhibitory measures to predict symptoms, neurocognitive deficits, functional status, and outcome) and """"""""top down"""""""" applications (e.g. applying these measures to understand the neural substrates of schizophrenia using lesion, pharmacological, and genetic manipulations) by using the interactive human and animal experiments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH042228-21
Application #
7194178
Study Section
Special Emphasis Panel (ZRG1-BDCN-6 (01))
Program Officer
Meinecke, Douglas L
Project Start
1987-01-01
Project End
2009-07-31
Budget Start
2007-03-01
Budget End
2009-07-31
Support Year
21
Fiscal Year
2007
Total Cost
$628,467
Indirect Cost
Name
University of California San Diego
Department
Psychiatry
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Thomas, Michael L; Patt, Virginie M; Bismark, Andrew et al. (2017) Evidence of systematic attenuation in the measurement of cognitive deficits in schizophrenia. J Abnorm Psychol 126:312-324
Thomas, Michael L; Green, Michael F; Hellemann, Gerhard et al. (2017) Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia. JAMA Psychiatry 74:37-46
Swerdlow, Neal R; Tarasenko, Melissa; Bhakta, Savita G et al. (2017) Amphetamine Enhances Gains in Auditory Discrimination Training in Adult Schizophrenia Patients. Schizophr Bull 43:872-880
Moore, Tyler M; Risbrough, Victoria B; Baker, Dewleen G et al. (2017) Effects of military service and deployment on clinical symptomatology: The role of trauma exposure and social support. J Psychiatr Res 95:121-128
Millard, Steven P; Shofer, Jane; Braff, David et al. (2016) Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophr Res 174:1-9
Swerdlow, Neal R; Braff, David L; Geyer, Mark A (2016) Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next. J Psychopharmacol 30:1072-1081
Tarasenko, Melissa; Perez, Veronica B; Pianka, Sean T et al. (2016) Measuring the capacity for auditory system plasticity: An examination of performance gains during initial exposure to auditory-targeted cognitive training in schizophrenia. Schizophr Res 172:123-30
Amitai, Nurith; Powell, Susan; Weber, Martin et al. (2015) Negative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine. Cogn Affect Behav Neurosci 15:901-14
Light, Gregory A; Swerdlow, Neal R; Thomas, Michael L et al. (2015) Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2. Schizophr Res 163:63-72
Powell, Susan B; Khan, Asma; Young, Jared W et al. (2015) Early Adolescent Emergence of Reversal Learning Impairments in Isolation-Reared Rats. Dev Neurosci 37:253-62

Showing the most recent 10 out of 272 publications